Asterias Biotherapeutics, Inc. Restructuring Charges
Asterias Biotherapeutics, Inc. reported Restructuring Charges of $500.00 thousand for the 3-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2018-03-15
- Asterias Biotherapeutics, Inc. restructuring charges for the quarter ending 2017-12-31 was $500.00K.
| Period end | Restructuring Charges 3 month |
|---|---|
| 2017-12-31 | $500.00K 10-K · filed 2018-03-15 |